Addex Therapeutics Ltd (ADXN) — Cash Flow-to-Debt Ratio
Addex Therapeutics Ltd (ADXN) has a Cash Flow-to-Debt Ratio of -0.38x as of March 2026, meaning its operating cash flow of $-608.40K could theoretically repay 0% of its total liabilities ($1.60 Million) in one year. Explore long-term investment intensity of Addex Therapeutics Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Addex Therapeutics Ltd Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Addex Therapeutics Ltd across 20 annual periods. Also explore balance sheet size of Addex Therapeutics Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Addex Therapeutics Ltd (2006–2025)
Year-by-year debt coverage analysis for Addex Therapeutics Ltd. For market capitalisation and broader financial context, see Addex Therapeutics Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.30x | $-2.08 Million | $1.60 Million | ▲ +75.8% |
| 2024 | -5.37x | $-5.37 Million | $1.00 Million | ▼ -134.8% |
| 2023 | -2.29x | $-7.99 Million | $3.50 Million | ▲ +53.1% |
| 2022 | -4.88x | $-16.44 Million | $3.37 Million | ▼ -86.1% |
| 2021 | -2.62x | $-14.71 Million | $5.61 Million | ▼ -19.9% |
| 2020 | -2.19x | $-12.18 Million | $5.57 Million | ▼ -73.0% |
| 2019 | -1.26x | $-9.48 Million | $7.50 Million | ▼ -314.4% |
| 2018 | 0.59x | $1.75 Million | $2.97 Million | ▲ +147.5% |
| 2017 | -1.24x | $-2.13 Million | $1.72 Million | ▲ +32.6% |
| 2016 | -1.84x | $-2.69 Million | $1.46 Million | ▲ +14.2% |
| 2015 | -2.14x | $-2.63 Million | $1.23 Million | ▼ -97.1% |
| 2014 | -1.09x | $-1.80 Million | $1.65 Million | ▲ +80.3% |
| 2013 | -5.53x | $-15.78 Million | $2.85 Million | ▼ -2.2% |
| 2012 | -5.41x | $-29.45 Million | $5.44 Million | ▼ -99.3% |
| 2011 | -2.71x | $-26.55 Million | $9.78 Million | ▲ +14.5% |
| 2010 | -3.18x | $-31.34 Million | $9.87 Million | ▲ +11.5% |
| 2009 | -3.59x | $-39.38 Million | $10.97 Million | ▼ -169.0% |
| 2008 | -1.33x | $-17.79 Million | $13.34 Million | ▲ +62.5% |
| 2007 | -3.56x | $-33.00 Million | $9.27 Million | ▲ +25.8% |
| 2006 | -4.80x | $-19.56 Million | $4.07 Million | — |